PRRT2 and breast cancer: In breast cancer cells, Zafar et al. found that chromatin-bound-PKCθ was part of an active transcription complex that controlled the expression of genes involved in the epithelial to mesenchymal transition (EMT) and cancer stem cell [54,56].